Sascha Tillmanns

PharmaSwiss SA engages in the provision of healthcare solutions. It also offers consulting services. The company was founded on January 24, 2000 and is headquartered in Zug, Switzerland.

American Chamber of Commerce in Germany eV engages in the enhancement of global economic and trade relations. The company was founded on January 29, 1903 and is headquartered in Frankfurt am Main, Germany.

Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris.

RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany.

BSN medical GmbH develops and markets wound care and related vascular diseases, lymphology and non-invasive orthopedic products. The firm specializes in the supply and manufacture of medical accessories for wound care, compression therapy, orthopedics, fracture management, physiotherapy and bandage applications. It markets products under brands, such as Leukoplast, Leukomed, Gypsona, Orthoglass, JOBSt, Radiante, Delta-cast, Actimove and Tridocur. Its focus areas encompass product innovation, brand development and hands-on training and workshops. The company was founded in April 2001 and is headquartered in Hamburg, Germany.

Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer.

Claudio BidCo A/S operates as an investment company with interests in development and manufacturing of medicated chewing gum. The company was founded on November 24, 2016 and is headquartered in Vejle, Denmark.

Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark.

Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.

Part of Takeda Pharmaceutical Co., Ltd., Shire Deutschland GmbH develops therapies for patients with rare and other specific diseases. The company is based in Berlin, Germany. The CEOs are Uwe Fröhlich, Heidrun Irschik-Hadjieff, Karsten Meisloch. The German company was founded in 1986.

Lophius Biosciences GmbH develops and markets T-cell-based diagnostic test systems. The firm specializes in the development of products for the diagnosis and immuno monitoring of virus-specific immune responses. It also provides customized services in the field of cell-based bioactivity, as well as quality tests for pharmaceutical active substances. The firm focuses on improving therapy control and personalized treatment of patients in the area of transplantation medicine and infectious and autoimmune diseases. The company was founded by Ludwig Deml and Fritz Schwarzmann in 2002 and it is headquartered in Regensburg, Germany.

Patheon UK Ltd. provides pharmaceutical drug development and manufacturing services. It provides its services to the pharmaceutical and biotechnology industries. The company is headquartered in Abingdon, UK

PARI Pharma GmbH Manufactures inhalant drugs. It offers aerosol inhalats and nebulizers which are primarily used against respiratory conditions. The company was founded in 1997 and is headquartered in Starnberg, Germany.

CM&D Pharma Ltd. provides pharmaceutical products. It is a specialty pharmacy company focused on foods for special medical purposes. Its products include Fostrap CKD, Recoclix, SilSOS, Eviendep, and Ossulin. The company was founded in 2007 and is headquartered in Surrey, UK.

Pharmathen SA develops, manufactures, and markets pharmaceuticals. Its products include a-cnotren, adicanil, alcinin, atostana, aurid, azapin, belifax, calci-10, deprevix cr, esmocard, farbovil, faxiven, depilonine pro, depilonine cream, aripiprazole, atorvastatin, brinzolamide, caspofungin, and clopidogrel. The company was founded in 1969 and is headquartered in Pallini, Greece.

Part of Convatec Group Plc, Convatec (Germany) GmbH wholesales pharmaceutical products. The company is based in Munich, Germany. The CEOs of the German company are Clare Jane Bates, Mercedes Armendariz, Tanja Dormels.

Part of Bristol Myers Squibb Co., Bristol-Myers Squibb GmbH & Co. KGaA is a German company that manufactures biopharmaceutical medicines. The company is based in Munich, Germany. The CEO of the company is Han Steutel.

ESBATech AG develops antibody fragment therapeutics. The firm's antibody fragment is derived from human antibody fragment scaffolds. It develops Immuna, an antigen-independent platform to screen, select, and optimize highly-stable and soluble, single-chain antibody fragments. The company was founded by Dominik Escher in September 1998 and is headquartered Schlieren, Switzerland.

Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom.

The Caisse de dépôt et placement du Québec (CDPQ) is a government-owned institutional fund manager headquartered in Montréal, Canada. Founded in 1965, CDPQ manages the funds of several depositor groups primarily for public and parapublic pension and insurance plans which pay out benefits to more than two million Quebecers each year.

Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland.

Lipideon Biotechnology AG engages in the provision of pharmaceutical activities. The company was founded on February 26, 2002 and is headquartered in Zurich, Switzerland.

Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland.